https://www.bioworld.com/articles/704223-msd-roche-highlight-new-sub-analysis-data-at-esmo-asia-in-asia-prevalent-cancers?v=preview
MSD, Roche highlight new sub analysis data at ESMO Asia in Asia-prevalent cancers | BioWorld
MSD had a banner year at the ESMO Asia Congress earlier this month, presenting 14 abstracts on eight different types of cancers, including gastric, esophageal,...
analysis dataesmo asiamsdrochehighlight
https://www.esmo.org/meeting-calendar/esmo-asia-2020-virtual/industry-sponsored-satellite-symposia/head-and-neck-cancer
ESMO Asia Virtual Congress 2020: Industry Sponsored Satellite Symposia - Head and Neck Cancer | ESMO
head and neckesmo asiasatellite symposiavirtualcongress
https://en.prnasia.com/releases/apac/abbvie-sponsored-symposium-at-esmo-asia-2025-highlights-urgent-medical-need-in-platinum-resistant-advanced-ovarian-cancer-514887.shtml
AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant...
SINGAPORE, Dec. 5, 2025 /PRNewswire/ -- AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian...
sponsored symposiumesmo asiaabbviehighlightsurgent
https://ogkologos.com/esmo-asia-virtual-congress-2020-20-22-november/
ESMO Asia Virtual Congress 2020, 20-22 November | Ogkologos.com
esmo asiavirtualcongressnovember
https://medically.roche.com/global/en/oncology/esmo-asia-2025.html
ESMO Asia 5 December - 7 December 2025 | Singapore, Republic of Singapore | Roche
esmo asiarepublic ofdecembersingaporeroche
https://mediamedic.co/esmo-asia-2024-dr-li-zhang-insights-from-the-booster-study-on-egfr-mutant-nsclc-treatment/
ESMO ASIA 2024 | Dr. Li Zhang: Insights from the BOOSTER Study on EGFR-Mutant NSCLC Treatment -...
Jan 17, 2025 - Epidermal growth factor receptor (EGFR) gene mutations are the most common oncogenic driver mutations in non-small cell lung cancer (NSCLC) patients in China,...
esmo asiali zhangfrom thedrinsights